Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.40093
PubMed Identifier: 28296257
Publication URI: http://europepmc.org/abstract/MED/28296257
Type: Journal Article/Review
Volume: 69
Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)
Issue: 7
ISSN: 2326-5191